|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0008976,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0038454,
umls-concept:C0175668,
umls-concept:C0199176,
umls-concept:C0201950,
umls-concept:C0286651,
umls-concept:C0301630,
umls-concept:C0392756,
umls-concept:C0428466,
umls-concept:C0441471,
umls-concept:C0577631,
umls-concept:C0580822,
umls-concept:C0936012,
umls-concept:C1547300,
umls-concept:C1548760,
umls-concept:C1550594
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2008-11-25
|
|
pubmed:abstractText |
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial found that treatment with atorvastatin 80 mg per day reduced the risk of stroke and cardiovascular events in patients with a recent transient ischemic attack (TIA) or stroke. We hypothesized this benefit would be greatest in the subgroup of patients with carotid stenosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1524-4628
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
39
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3297-302
|
|
pubmed:dateRevised |
2009-2-23
|
|
pubmed:meshHeading |
pubmed-meshheading:18845807-Aged,
pubmed-meshheading:18845807-Brain Ischemia,
pubmed-meshheading:18845807-Carotid Stenosis,
pubmed-meshheading:18845807-Cerebral Hemorrhage,
pubmed-meshheading:18845807-Cholesterol, LDL,
pubmed-meshheading:18845807-Coronary Disease,
pubmed-meshheading:18845807-Female,
pubmed-meshheading:18845807-Heptanoic Acids,
pubmed-meshheading:18845807-Humans,
pubmed-meshheading:18845807-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:18845807-Hypercholesterolemia,
pubmed-meshheading:18845807-Ischemic Attack, Transient,
pubmed-meshheading:18845807-Male,
pubmed-meshheading:18845807-Middle Aged,
pubmed-meshheading:18845807-Pyrroles,
pubmed-meshheading:18845807-Randomized Controlled Trials as Topic,
pubmed-meshheading:18845807-Recurrence,
pubmed-meshheading:18845807-Risk,
pubmed-meshheading:18845807-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
|
|
pubmed:affiliation |
Department of Vascular Surgery, Rigshospitalet, University of Copenhagen, Copenhagen O, Denmark. Sillesen@mac.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
